Clinical trial
RUPP PI PDD: Drug and Behavioral Therapy for Children With Pervasive…
NCT00080145 · Yale University, Other · Completed
Key facts
| NCT number | NCT00080145 |
|---|---|
| Title | RUPP PI PDD: Drug and Behavioral Therapy for Children With Pervasive Developmental Disorders |
| Official title | Risperidone and Behavioral Therapy in Treatment of Children and Adolescents With Autistic Disorder |
| Lead sponsor | Yale University, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Child Development Disorders, Pervasive |
| Intervention type | Behavioral, Drug |
| Interventions | Risperidone, Behavior Therapy |
| Enrollment | 124 |
| Start date | Feb 1, 2004 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Mar 25, 2004 |
| Last update posted | Aug 16, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: